Should Iron Supplementation Be Started When Ferritin Is Low?
Yes, iron supplementation should be started when ferritin is low, but the specific threshold and route depend on the clinical context. For most adults without inflammatory conditions, start oral iron when ferritin is ≤30 ng/mL; for restless legs syndrome (RLS), consider oral iron when ferritin is ≤75 μg/L and intravenous iron when ferritin is 75-300 μg/L 1, 2.
Key Diagnostic Thresholds
The most recent high-quality evidence establishes different ferritin cutoffs based on clinical context:
General Adult Population
- Ferritin ≤30 ng/mL is the optimal threshold for diagnosing iron deficiency in adults without inflammatory conditions 2
- This threshold balances sensitivity (avoiding missed diagnoses) with specificity (avoiding unnecessary treatment)
- The 2026 American Society of Hematology guidelines prioritized this cutoff after analyzing that it minimizes false negatives while limiting false positives 2
Restless Legs Syndrome (Most Detailed Guidelines)
The 2026 Mayo Clinic algorithm provides the most comprehensive framework 1:
Oral iron indicated when:
- Ferritin ≤75 μg/L AND transferrin saturation (TSAT) <45%
- Dose: 65 mg elemental iron once daily or every other day (alternate-day dosing may improve absorption)
- Take at night (iron preferentially transported to brain at night)
- Add 100-200 mg vitamin C to enhance absorption
- Recheck ferritin after 3 months
Intravenous iron indicated when:
- Ferritin 75-300 μg/L with TSAT <45%, OR
- Ferritin <75 μg/L with TSAT <45% AND one of: oral iron intolerance, malabsorption, no improvement after 3 months oral iron, or severe symptoms requiring rapid response 1
Special Populations
Inflammatory conditions (IBD, CKD, heart failure):
- Use TSAT <20% as better indicator when ferritin may be falsely elevated 1
- Consider intravenous iron as first-line therapy 3, 4
Pregnancy:
- Ferritin >70 ng/mL prevents iron deficiency throughout gestation 4
- Screening at 30 μg/L threshold is cost-effective in second and third trimesters 5
Athletes:
- Ferritin <35 μg/L defines iron deficiency 6
- Prioritize dietary iron from meat sources; supplement if needed
Critical Caveats
Do NOT Give Iron Empirically
Never start iron without checking ferritin first because:
- May cause hepatic iron overload in undiagnosed hemochromatosis 1
- If TSAT ≥45% on multiple occasions, test for hemochromatosis before any iron 1
Investigate the Cause
When ferritin is below normal for age/sex, search for underlying causes 1:
- Menorrhagia
- GI bleeding (consider bidirectional endoscopy in men and postmenopausal women with iron deficiency anemia) 4
- Malabsorption (celiac disease, bariatric surgery)
- Proton pump inhibitors or H2 blockers
- Vegan diet
- Frequent blood donation
Timing of Testing
- Obtain ferritin and TSAT before starting oral iron (oral iron affects hepcidin and absorption for 48 hours) 1
- Wait at least 48 hours after last oral iron dose before testing 1
Route Selection Algorithm
Choose ORAL iron when:
- Ferritin ≤30-75 μg/L (depending on indication)
- No malabsorption
- Can tolerate GI side effects
- Not pregnant (second/third trimester)
- No active inflammatory bowel disease
Choose INTRAVENOUS iron when:
- Chronic kidney disease, heart failure, inflammatory bowel disease, or cancer 4, 7
- Oral iron intolerance or malabsorption
- Post-bariatric surgery 4
- Pregnancy (second/third trimester) 7
- Ferritin 75-300 μg/L with RLS 1
- Need rapid response for severe symptoms
Treatment Targets
- Hemoglobin: 10-12 g/dL or normalization 8
- Ferritin: Generally >100 μg/L, but not exceeding 500-800 μg/L in CKD 8
- For RLS: No specific ferritin goal; assess clinical response at 6-8 weeks 1
Evidence Strength
The recommendations prioritize the 2026 Mayo Clinic RLS guidelines [1-1] as the most recent, comprehensive, and algorithmically structured guidance, with the 2026 American Society of Hematology guidelines 2 providing the strongest evidence for the 30 ng/mL threshold in general populations. The 2025 Lancet Haematology consensus 4 and 2025 JAMA review 7 provide important supporting evidence for special populations.
Research demonstrates that even nonanemic women with ferritin <50 μg/L experience significant fatigue improvement with iron supplementation (29% vs 13% with placebo, p=0.004) 9, 10, supporting treatment at these thresholds for quality of life benefits beyond just preventing anemia.